Quantification of longitudinal patient-reported burden of adverse drug reactions attributed to the use of TNF-α inhibitors in inflammatory rheumatic diseases: an observational prospective cohort study

• Benthe H KönigNetherlands Pharmacovigilance Centre Lareb
• Helen R. GosseltNetherlands Pharmacovigilance Centre Lareb
• Jette A. van LintNetherlands Pharmacovigilance Centre Lareb
• Leanne J. KosseNetherlands Pharmacovigilance Centre Lareb
• Bart J. F. van den BemtRadboud University Nijmegen
• Peter M. ten KloosterUniversity of Twente
• Harald E. VonkemanMedisch Spectrum Twente
• Naomi T. JessurunNetherlands Pharmacovigilance Centre Lareb